Compare Newegg Commerce Inc (NEGG) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newegg Commerce Inc vs BIO-TECHNE Corp — how do they compare? Newegg Commerce Inc trades at $18.97 (market cap $380.46M), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 29.5× Newegg Commerce Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Newegg Commerce Inc pays none. Which is the better fit depends on your goals.
| NEGG | TECH | |
|---|---|---|
Market Cap | $380.46M | $11.24B |
Sector | Consumer Cyclical | Health |
52-Week High | $128.09 | $72.29 |
52-Week Low | $12.87 | $43.31 |
Enterprise Value | $379.26M | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NEGG (Newegg Commerce) trades at $16.9, down 5.48% today, with a bullish technical signal from moving averages but an overbought RSI. The company reported a net loss of $4.88M in 2025, though revenue grew to $1.44B, and it has beaten EPS estimates in recent quarters. Recent news highlights product launches and AI shopping enhancements, signaling innovation efforts.
The outlook is mixed: profitability remains weak with a net margin of 0.39%, but low P/S of 0.26 suggests undervaluation. Risks include persistent negative cash flow from operations and high competition. Analyst consensus is bullish with 100% buy ratings, but investors should monitor earnings sustainability and cost management.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
